基因组工程市场－全球产业规模、份额、趋势、机会和预测，按技术、交付方式、应用、最终用户、地区和竞争格局划分，2021-2031年预测

全球基因组工程市场规模预计将从2025年的114.1亿美元成长至2031年的284.5亿美元，年复合成长率达16.45%。基因组工程是指利用CRISPR-Cas9、TALENs和ZFNs等技术，对生物体的遗传物质进行精确改造，以插入、删除或改变DNA序列。该市场的主要驱动力是遗传性疾病和慢性病盛行率的上升，以及基因组研究领域的大量投资和基因编辑技术在农业和治疗领域的应用不断扩展。

主要市场驱动因素

CRISPR 和新一代基因编辑工具的持续进步正在从根本上重塑市场格局，将基因组工程从实验研究转变为具有商业可行性的治疗方法。首批基于 CRISPR 的镰状细胞贫血症和β-地中海贫血疗法的成功核准和随后的商业化推广，便是这一转变的典型例证。

主要市场挑战

高昂的治疗费用和复杂的报销模式构成了基因组工程市场成长的重大障碍。基因组药物的研发涉及资本密集的研发和生产过程，因此必须定价高昂才能回收投资。

主要市场趋势

人工智慧和机器学习的融合正在从根本上改变基因组设计格局，显着提升编辑工具的精确度。这些计算技术使研究人员能够以前所未有的速度预测脱靶效应并优化引导RNA序列，从而大幅缩短治疗药物的研发週期。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球基因组工程市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依技术分类（CRISPR、TALEN、ZFN、反义寡核苷酸、其他）
  • 依交付方式（体外交付与体内交付）
  • 依应用领域（细胞株工程、基因工程、诊断应用、药物发现与开发、其他）
  • 按最终用户（製药和生物技术公司、学术和研究机构、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美基因组工程市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲基因组工程市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太基因组工程市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲基因组工程市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲基因组工程市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球基因组工程市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Merck KGaA
• Sangamo Therapeutics, Inc.
• GenScript Biotech Corp
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Precision BioSciences, Inc.
• Horizon Discovery Group plc
• Lonza Group Ltd.
• OriGene Technologies, Inc.
• Transposagen Biopharmaceuticals, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Genome Engineering Market will grow from USD 11.41 Billion in 2025 to USD 28.45 Billion by 2031 at a 16.45% CAGR. Genome engineering is the precise modification of an organism's genetic material using technologies such as CRISPR-Cas9, TALENs, and ZFNs to insert, delete, or alter DNA sequences. The market is primarily driven by the rising prevalence of genetic and chronic diseases, coupled with substantial investments in genomic research and the expanding application of gene editing in agriculture and therapeutics.

Key Market Drivers

Continuous advancements in CRISPR and next-generation editing tools are fundamentally reshaping the market by transitioning genome engineering from experimental research to commercially viable therapeutics. This shift is exemplified by the regulatory success and subsequent commercial rollout of the first CRISPR-based treatments for sickle cell disease and beta-thalassemia. The ability to precisely correct genetic defects ex vivo has validated the clinical utility of these technologies, encouraging rapid adoption across healthcare systems and validating the commercial potential of gene-edited medicines.

Key Market Challenges

The high cost of treatment and the complexity of reimbursement models constitute a substantial barrier to the growth of the genome engineering market. Developing genomic medicines involves capital-intensive research and manufacturing processes which necessitates high pricing to recoup investments. Consequently, these elevated costs place a severe strain on healthcare budgets and insurance providers often limiting patient eligibility and delaying coverage decisions. This financial friction prevents these therapies from reaching a wider patient population, thereby restricting the total addressable market and slowing the revenue generation required to sustain further industry innovation.

Key Market Trends

The integration of artificial intelligence and machine learning is fundamentally altering the genomic design landscape by improving the precision of editing tools. These computational technologies enable researchers to predict off-target effects and optimize guide RNA sequences with unprecedented speed, significantly reducing the timeline for therapeutic development. This convergence of biology and computation is attracting massive investment to support generative models that can design novel biological systems from scratch.

Key Market Players

• Merck KGaA
• Sangamo Therapeutics, Inc.
• GenScript Biotech Corp
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Precision BioSciences, Inc.
• Horizon Discovery Group plc
• Lonza Group Ltd.
• OriGene Technologies, Inc.
• Transposagen Biopharmaceuticals, Inc.

Report Scope:

In this report, the Global Genome Engineering Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genome Engineering Market, By Technology:

• CRISPR
• TALEN
• ZFN
• Antisense
• Others

Genome Engineering Market, By Delivery Method:

• Ex-Vivo v/s In-Vivo

Genome Engineering Market, By Application:

• Cell Line Engineering
• Genetic Engineering
• Diagnostic Applications
• Drug Discovery & Development
• Others

Genome Engineering Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Others

Genome Engineering Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Genome Engineering Market.

Available Customizations:

Global Genome Engineering Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genome Engineering Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (CRISPR, TALEN, ZFN, Antisense, Others)
  • 5.2.2. By Delivery Method (Ex-Vivo v/s In-Vivo)
  • 5.2.3. By Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Others)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Genome Engineering Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Delivery Method
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Genome Engineering Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Delivery Method
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Genome Engineering Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Delivery Method
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Genome Engineering Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Delivery Method
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Genome Engineering Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Delivery Method
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Genome Engineering Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Delivery Method
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Genome Engineering Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Delivery Method
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Genome Engineering Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Delivery Method
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Genome Engineering Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Delivery Method
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Genome Engineering Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Delivery Method
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Genome Engineering Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Delivery Method
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Genome Engineering Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Delivery Method
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Genome Engineering Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Delivery Method
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Genome Engineering Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Delivery Method
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Genome Engineering Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Delivery Method
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Genome Engineering Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Delivery Method
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Genome Engineering Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Delivery Method
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Genome Engineering Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Delivery Method
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Genome Engineering Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Delivery Method
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Genome Engineering Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Delivery Method
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Genome Engineering Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Delivery Method
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Genome Engineering Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Delivery Method
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Genome Engineering Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Delivery Method
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Genome Engineering Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Delivery Method
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Genome Engineering Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sangamo Therapeutics, Inc.
• 15.3. GenScript Biotech Corp
• 15.4. CRISPR Therapeutics AG
• 15.5. Editas Medicine, Inc.
• 15.6. Precision BioSciences, Inc.
• 15.7. Horizon Discovery Group plc
• 15.8. Lonza Group Ltd.
• 15.9. OriGene Technologies, Inc.
• 15.10. Transposagen Biopharmaceuticals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer